In cancer progression, LRPPRC was also reported to be associated with mitochondria by interacting with Parkin and thus stabilizing Parkin substrates, including Bcl-2 and Parkin itself to inhibit autophagy, and consequently, LRPPRC protects mitochondria from autophagy degradation (Zou et al., 2013). This evidence concerns the gene BCL2 and cancer.